1. Academic Validation
  2. Imidazoline- and Benzamidine-Based Trypanosome Alternative Oxidase Inhibitors: Synthesis and Structure-Activity Relationship Studies

Imidazoline- and Benzamidine-Based Trypanosome Alternative Oxidase Inhibitors: Synthesis and Structure-Activity Relationship Studies

  • ACS Med Chem Lett. 2022 Jan 28;13(2):312-318. doi: 10.1021/acsmedchemlett.1c00717.
David Cisneros 1 Eduardo J Cueto-Díaz 1 Tania Medina-Gil 1 Rebecca Chevillard 1 Teresa Bernal-Fraile 1 Ramón López-Sastre 1 Mustafa M Aldfer 2 Marzuq A Ungogo 2 Hamza A A Elati 2 Natsumi Arai 3 Momoka Otani 3 Shun Matsushiro 3 Chiaki Kojima 3 Godwin U Ebiloma 3 4 Tomoo Shiba 3 Harry P de Koning 2 Christophe Dardonville 1
Affiliations

Affiliations

  • 1 Instituto de Química Médica, IQM-CSIC, Juan de la Cierva 3, E-28006 Madrid, Spain.
  • 2 Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom.
  • 3 Graduate School of Science and Technology, Department of Applied Biology, Kyoto Institute of Technology, Kyoto 606-8585, Japan.
  • 4 School of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, United Kingdom.
Abstract

The trypanosome alternative oxidase (TAO), a mitochondrial enzyme involved in the respiration of the bloodstream form trypomastigotes of Trypanosoma brucei, is a validated drug target against African trypanosomes. Earlier series of TAO inhibitors having a 2,4-dihydroxy-6-methylbenzoic acid scaffold ("head") and a triphenylphosphonium or quinolin-1-ium cation as a mitochondrion-targeting group ("tail") were shown to be nanomolar inhibitors in enzymatic and cellular assays. We investigated here the effect of different mitochondrion-targeting cations and Other scaffold modifications on the in vitro activity of this class of inhibitors. Low micromolar range activities were obtained, and the structure-activity relationship studies showed that modulation of the tail region with polar substituents is generally detrimental to the enzymatic and cellular activity of TAO inhibitors.

Figures